, finding that higher 25(OH)D levels were predictive of reduced MS activity and a slower rate of progression.Among patients with MS mainly treated with interferon beta-1b, low 25[OH]D levels early in the disease course are a strong risk factor for long-term MS activity and progression, wrote Ascherio and his colleagues.Study detailsThe team noted that MS is a common cause of neurological disabil